180 Degree Capital Corp. is on record against 3 companies.
180 Degree Capital Corp. is an investment firm whose portfolio reveals a strong orientation toward deep technology and life sciences, with particular emphasis on companies developing novel materials, biotechnology, clean energy, and advanced semiconductor solutions. The firm's holdings span a broad range of science-driven businesses, including agricultural biology, quantum computing, solid-state lighting, nanotechnology, synthetic biology, and genomics, reflecting a conviction that transformative value can be created at the intersection of fundamental scientific research and commercial application. Within the life sciences, 180 Degree Capital has backed companies working in oncology, tissue engineering, diagnostics, drug delivery, and metabolic analysis, suggesting an appetite for early and growth-stage ventures addressing unmet needs in human health. On the materials and hardware side, the portfolio includes businesses focused on semiconductor fabrication, water treatment, display technologies, and photovoltaics, indicating a parallel interest in companies translating laboratory-scale innovations into scalable industrial products. Across its portfolio, the firm demonstrates a consistent pattern of engaging with companies whose competitive advantages are rooted in proprietary science and intellectual property rather than incremental product differentiation. This approach positions 180 Degree Capital as an investor willing to accept the longer development timelines and technical risks characteristic of deep technology ventures in exchange for the potential of category-defining outcomes in sectors undergoing fundamental transformation.